Royal London Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.9M Buy
106,539
+131
+0.1% +$32.6K 0.05% 292
2025
Q4
$25.6M Sell
106,408
-1,665
-2% -$426K 0.05% 274
2025
Q3
$29.6M Sell
108,073
-1,296
-1% -$354K 0.06% 257
2025
Q2
$28.2M Sell
109,369
-1,873
-2% -$447K 0.06% 256
2025
Q1
$24.9M Buy
111,242
+34,430
+45% +$8.04M 0.06% 268
2024
Q4
$17.6M Buy
76,812
+4,094
+6% +$986K 0.04% 325
2024
Q3
$17.8M Buy
72,718
+1,624
+2% +$363K 0.04% 317
2024
Q2
$13.6M Buy
71,094
+1,070
+2% +$217K 0.03% 348
2024
Q1
$13.9M Buy
70,024
+77
+0.1% +$14.1K 0.03% 344
2023
Q4
$12M Buy
69,947
+1,335
+2% +$205K 0.03% 353
2023
Q3
$10.1M Buy
68,612
+15,404
+29% +$2.79M 0.03% 358
2023
Q2
$11.6M Buy
53,208
+2,410
+5% +$537K 0.04% 331
2023
Q1
$11.1M Buy
50,798
+936
+2% +$203K 0.04% 308
2022
Q4
$10.4M Buy
49,862
+2,580
+5% +$567K 0.05% 319
2022
Q3
$10.3M Sell
47,282
-3,503
-7% -$797K 0.05% 295
2022
Q2
$10.7M Buy
50,785
+64
+0.1% +$13.6K 0.05% 286
2022
Q1
$12.3M Buy
50,721
+2,408
+5% +$582K 0.05% 294
2021
Q4
$12.6M Sell
48,313
-3,369
-7% -$874K 0.05% 301
2021
Q3
$13.6M Sell
51,682
-2,616
-5% -$715K 0.06% 271
2021
Q2
$13.4M Hold
54,298
0.05% 280
2021
Q1
$10.5M Buy
54,298
+750
+1% +$150K 0.05% 304
2020
Q4
$11.4M Sell
53,548
-760
-1% -$152K 0.06% 265
2020
Q3
$9.38M Sell
54,308
-651
-1% -$120K 0.06% 270
2020
Q2
$10.3M Sell
54,959
-2,419
-4% -$396K 0.07% 239
2020
Q1
$8.84M Hold
57,378
0.07% 241
2019
Q4
$8.87M Buy
57,378
+631
+1% +$90.9K 0.06% 292
2019
Q3
$7.67M Buy
56,747
+675
+1% +$88.4K 0.06% 312
2019
Q2
$6.84M Hold
56,072
0.06% 283
2019
Q1
$5.83M Sell
56,072
-4,108
-7% -$424K 0.05% 376
2018
Q4
$6.74M Buy
60,180
+1,747
+3% +$187K 0.06% 323
2018
Q3
$6.74M Sell
58,433
-2,409
-4% -$264K 0.07% 277
2018
Q2
$6.3M Buy
+60,842
New +$6.16M 0.06% 319

Other funds holding RMD